Archeus Technologies Looks To Bring Potentially Game-Changing Anti-Cancer Agent To Market

Isthmus Project’s investment portfolio is expanding, thanks to an upcoming and perhaps game-changing tool in the fight to save the lives of cancer patients. Fueled by decades of pre-clinical study, $20 million in support from the National Institutes of Health (NIH), and a world-class team of about 75 University of Wisconsin experts representing every facet of cancer research, this novel approach to fighting cancer appears to show promise. In 2023, Isthmus Project invested in Archeus Technologies, a Madison-based biotech startup that seeks to bring the concept to market.

Read more: https://www.isthmusproject.com/story/archeus-technologies-looks-to-bring-potentially-game-changing-anti-cancer-agent-to-market/